GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elbit Imaging Ltd (OTCPK:EMITF) » Definitions » Institutional Ownership

EMITF (Elbit Imaging) Institutional Ownership : 0.01% (As of Jan. 18, 2025)


View and export this data going back to 1996. Start your Free Trial

What is Elbit Imaging Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Elbit Imaging's institutional ownership is 0.01%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Elbit Imaging's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Elbit Imaging's Float Percentage Of Total Shares Outstanding is 0.00%.


Elbit Imaging Institutional Ownership Historical Data

The historical data trend for Elbit Imaging's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elbit Imaging Institutional Ownership Chart

Elbit Imaging Historical Data

The historical data trend for Elbit Imaging can be seen below:

2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31
Institutional Ownership 0.01 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04

Elbit Imaging Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Elbit Imaging Business Description

Traded in Other Exchanges
Address
3 Shimshon Street, Olympia A Tower, Petach Tikva, ISR, 4900102
Elbit Imaging Ltd is an Israel based company. The business activity of the group is operated through two segments including Medical industries and devices, and Plots in India. Geographically the business presence is in the region of America, Europe, and ROW. The company derives maximum revenue from the Medical industries and devices segment which operates in the field of life science that includes development, production, and marketing of treatment-oriented medical systems, and for certain cancer diseases in the America region.